Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alabama for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alabama only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alabama (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

William Mcevoy (NPI 1821222761)

Field	Value
Entity Type	Individual
Organization	William Mcevoy
Address	29653 Anchor Cross Blvd
City	Daphne
State	AL
ZIP	36526
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	May 6, 2009

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

This provider is effectively single‑payer: Total Medicare revenue is $1.7M while Total Medicaid revenue is none (no Medicaid billing on file), indicating all reported public‑payer activity comes through Medicare and that Medicaid does not appear in the payer mix. That concentration increases sensitivity to Medicare reimbursement and utilization patterns for oncology services.

Revenue is highly concentrated in a small number of drugs and services: the precomputed top‑3 Medicare codes account for 83.3% of Medicare revenue, with J9271 alone representing $911.6K (57.5% of this provider's total Medicare revenue). This level of concentration implies the practice’s financial profile depends heavily on infusion drug administration rather than volume of routine office visits.

The code mix and top revenue drivers are consistent with an outpatient oncology infusion practice: dominant billing for J9271 (pembrolizumab) and J0897 (denosumab) alongside chemotherapy administration codes such as 96413 and G0498 shows care centered on high‑cost oncology injections and associated infusion services. Presence of E/M codes (99214, 99213) and chemotherapy administration add‑on codes (96417, 96367) indicate the clinic also manages evaluation and ongoing infusion follow‑up.

Competitive standing varies by code: J0897 ranks #371 of 10057 nationally (96th percentile; notably above typical national volume for this code), signaling unusually high denosumab volume versus peers, while 99214 ranks #11594 of 479517 (98th percentile; notably above typical national volume), indicating above‑typical office visit volume. By contrast, J9271 ranks #340 of 1841 (81th percentile; typical, unremarkable volume for this code), so pembrolizumab revenue is large in dollar terms but not exceptional in national ranking.

Operational and ancillary service pattern: substantial claims for blood draws and panels (36415: 1.7K claims, $13.4K revenue; 80053: 1.3K claims, $13.1K revenue) alongside pathology/flow cytometry (88185) reflect routine lab monitoring and diagnostic support consistent with active oncology care. These lab and specimen counts support an infusion workflow that requires frequent laboratory surveillance and tie closely to infusion throughput.

Several procedure codes are flagged as “notably above typical” activity, highlighting throughput strengths: 96367 (739 claims) is noted as notably above typical national volume, and 96372 (484 claims) and 99214 (995 claims) are also described as notably above typical. Those labels point to comparatively elevated rates of additional infusions, injection procedures, and moderate‑complexity follow‑up visits relative to national peers.

The provider’s tenure is long enough to establish an ongoing referral and treatment footprint: NPI enumerated 2009-05-06 (~17 years ago), which, combined with $1.7M in lifetime Medicare revenue, suggests an established specialty practice that has built a targeted oncology treatment mix over time. That longevity supports the interpretation that the current code mix reflects stable clinical focus rather than a transient billing pattern.

While several high‑volume chemotherapy and injection codes are present, many common monitoring and E/M codes are characterized as typical or unremarkable in national comparisons (for example, 36415 and many lab CPTs are labeled typical, unremarkable volume). This suggests the practice’s distinguishing financial feature is drug/injection revenue concentration rather than an outsized share of routine outpatient evaluation relative to peers.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

65 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	21,200	$40	$911.6K
J0897	Injection, denosumab, 1 mg	17,760	$20	$319.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,000	$90	$88.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	540	$90	$48.1K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	5,040	$10	$30.2K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	510	$60	$29.7K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community…	110	$170	$18.6K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	740	$20	$14.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	110	$120	$13.6K
36415	In this procedure, the provider inserts a needle into a vein to collect a blood sample.	1,680	$10	$13.4K

Showing 1–10 of 65

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 65 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alabama Distribution

William Mcevoy — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alabama

Full comparison — all codes billed, vs. state median

65 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	13	30	19,900	$40	$827.2K
J0897	11	200	3,120	$20	$97.7K
83521	5	10	40	$20	$26K
Q5106	4	10	2,650	$10	$23.6K
J9217	43	50	130	$130	$22.4K
96413	16	150	150	$90	$20.2K
99214	173	7,330	120	$80	$16.8K
88185	13	30	490	$20	$15.4K
99233	1,494	1,860	80	$90	$13.4K
80053	38	670	140	$10	$13.1K

Showing 1–10 of 65

Related Providers

Other providers that share a Tax Identification Number (TIN) with William Mcevoy, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ali Hachem	AL	Hematology & Oncology Physician	$2.3M	$0
Brian Heller	AL	Hematology & Oncology Physician	$2.3M	$0
Joseph Jones	AL	Hematology & Oncology Physician	$1.6M	$0
Michael Meshad	AL	Hematology & Oncology Physician	$1.1M	$0
Jeffrey George	AL	Hematology & Oncology Physician	$1.1M	$0
Rachel Kruspe	AL	Hematology & Oncology Physician	$1M	$0
Nicole Angel	AL	Medical Oncology Physician	$985.3K	$0
Rosa Michel Ortega	AL	Hematology & Oncology Physician	$731.7K	$0
Rachael Harmon	AL	Radiation Oncology Physician	$729.3K	$0
Brittany Case	AL	Medical Oncology Physician	$727.3K	$0

Nearby Providers

Other providers in the same ZIP code as William Mcevoy, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Eastern Shore Developmental Clinic	AL	Nurse Practitioner	$0	$4M
Daphne Pediatric Dentistry Inc	AL	Pediatric Dentistry	$0	$2M
Kids Kount Therapy Services, LLC	AL	Early Intervention Provider Agency	$0	$1.5M
Autism Behavior And Cognitive Development LLC	AL	Community/Behavioral Health Agency	$0	$1.2M
American Autism & Rehabilitation Center Inc	AL	Occupational Therapist	$0	$862.3K
David Thomason	AL	Physical Medicine & Rehabilitation Physician	$536.1K	$0
Jonathan Rainer	AL	Physical Medicine & Rehabilitation Physician	$418.9K	$0
Alan Stanford	AL	Dermatology Physician	$198K	$0
James Spain	AL	Sports Medicine (Family Medicine) Physician	$176.4K	$0
John Todd	AL	Specialist	$146.1K	$0

William Mcevoy — Billing Profile & Reimbursement Data

Sign up for William Mcevoy — Billing Profile & Reimbursement Data policy alerts

William Mcevoy — Billing Profile & Reimbursement Data

Sign up for William Mcevoy — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References